GMO U.S. Value ETF (NYSEARCA:GMOV) Sees Large Increase in Short Interest

GMO U.S. Value ETF (NYSEARCA:GMOVGet Free Report) was the target of a significant increase in short interest in the month of August. As of August 31st, there was short interest totaling 3,614 shares, an increase of 610.0% from the August 15th total of 509 shares. Based on an average trading volume of 7,807 shares, the short-interest ratio is currently 0.5 days. Approximately 0.1% of the company’s stock are sold short.

GMO U.S. Value ETF Trading Down 0.2%

Shares of NYSEARCA GMOV opened at $32.59 on Friday. The firm has a market cap of $104.29 million, a PE ratio of 12.08 and a beta of 0.63. GMO U.S. Value ETF has a 1-year low of $25.66 and a 1-year high of $33.34. The company has a fifty day moving average price of $31.88 and a 200 day moving average price of $30.18.

GMO U.S. Value ETF Cuts Dividend

The company also recently declared a quarterly dividend, which was paid on Wednesday, July 1st. Stockholders of record on Tuesday, June 30th were issued a $0.1283 dividend. This represents a $0.51 dividend on an annualized basis and a dividend yield of 1.6%. The ex-dividend date was Tuesday, June 30th.

Institutional Inflows and Outflows

A number of hedge funds have recently modified their holdings of GMOV. Fifth Third Bancorp acquired a new stake in GMO U.S. Value ETF in the 1st quarter valued at approximately $84,000. Pathway Financial Advisors LLC acquired a new position in GMO U.S. Value ETF during the 2nd quarter worth approximately $246,000. Kestra Private Wealth Services LLC acquired a new position in GMO U.S. Value ETF during the 1st quarter worth approximately $333,000. Aspen Investment Management Inc bought a new position in shares of GMO U.S. Value ETF during the 4th quarter worth approximately $333,000. Finally, RPS Advisory Solutions LLC bought a new position in shares of GMO U.S. Value ETF during the 4th quarter worth approximately $484,000.

GMO U.S. Value ETF Company Profile

(Get Free Report)

The GMO US Value ETF (GMOV) is an exchange-traded fund that mostly invests in total market equity. The fund is actively managed, investing primarily in US equity securities. The fund seeks to identify undervalued US stocks using proprietary quantitative methods, capitalizing on perceived market dislocations GMOV was launched on Oct 28, 2024 and is issued by GMO.

See Also

Receive News & Ratings for GMO U.S. Value ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GMO U.S. Value ETF and related companies with MarketBeat.com's FREE daily email newsletter.